FIGURE

Fig. 4

ID

ZDB-FIG-190218-12

Publication

Pott et al., 2018 - Therapeutic Chemical Screen Identifies Phosphatase Inhibitors to Reconstitute PKB Phosphorylation and Cardiac Contractility in ILK-Deficient Zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Calyculin A reconstitutes contractile force, PKB phosphorylation and anf expression in msq. (A) Ventricular FS of homozygous mutant msq embryos (msq−/−) in comparison to wild-type (WT) zebrafish. Homozygous msq embryos treated with 100 nmol/L calyculin A during 4–96 hpf displayed improved contractile force (25.4 ± 18.9% (p = 0.00015) compared to embryos incubated with DMSO (2.2 ± 5.3%). (n.s.: Not significant) (B) Treatment of homozygous msq−/− embryos with 100 nmol/L calyculin A displayed an increased PKB phosphorylation (pPKB) in comparison to controls. In situ hybridization revealed that calyculin A treated homozygous msq−/− embryos (E) show, in contrast to DMSO-treated wild-type zebrafish (C) and DMSO-treated msq−/− embryos (D), an almost indistinguishable anf expression.

Expression Data

Gene:	nppa
Antibody:	Ab9-akt
Fish:	WT ilk^m347/m347
Condition:	chemical treatment: calyculin a
Anatomical Terms:	heart whole organism
Stage Range:	Protruding-mouth to Day 4

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	WT ilk^m347/m347
Condition:	chemical treatment: calyculin a
Observed In:	heart whole organism
Stage Range:	Protruding-mouth to Day 4

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomolecules